Small increase in heart risk from common painkillers
With prolonged use, some widely used painkillers called non-steroidal anti-inflammatory drugs (NSAIDs) increase the risk of heart attacks by a small but significant amount, according to research published online in today’s The Lancet. 30 May 2013
MRC and Wellcome Trust invest £24m in Cambridge obesity institute
The Medical Research Council (MRC) and Wellcome Trust are to invest £24m into obesity research led by the Wellcome Trust-MRC Institute of Metabolic Science (IMS). 29 May 2013
New drug could protect from tissue damage following heart attack
Scientists led by the Medical Research Council (MRC) and University of Cambridge have developed a new drug that could help reduce the tissue damage that occurs following a heart attack, stroke or major surgery. 29 May 2013
Researchers shed light on role of genes in autism
6 June 2013
Research carried out by Medical Research Council (MRC) researchers at the University of Oxford has uncovered a chain of genetic events that are common in individuals with autism
Malaria virulence is regulated by mosquito transmission
29 May 2013
Transmission of the malaria parasite, known as Plasmodium, from mouse to mouse is far more likely to result in a severe malaria infection than one that has come from mosquito to mouse.
Her Majesty the Queen opens the new MRC Laboratory of Molecular Biology
23 May 2013
The new building for the Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) in Cambridge will be officially opened by Her Majesty the Queen on Thursday 23 May.
Vitamin D could provide new and effective treatments for asthma
20 May 2013
Vitamin D has the potential to significantly reduce the symptoms of asthma, according to a new study from the Medical Research Council (MRC)-Asthma UK Centre in Allergic Mechanisms of Asthma, at King’s College London.
B vitamins can slow the Alzheimer’s disease-related shrinkage of the brain
20 May 2013
Further analysis of the 2010 VITACOG clinical trial on elderly people with memory problems has shown that high doses of three B vitamins may slow down the shrinkage of the specific parts of the brain that are vulnerable to Alzheimer’s disease.
Find older items in our News Archive